Recent applications for approval also include another DMD therapy, another hemophilia B gene therapy, and a new antibiotic.

The European Medicines Agency has started reviewing a new batch of medicines for potential pan-EU marketing approval.

The French firm is searching for a US partner with strong foundations in the hospital sector after securing EU and China deals for its complicated urinary tract infection candidate that combines cefepime and enmetazobactam, which is nearing regulatory submission in key markets.

Licensing deals and partnerships carried the day during another hectic J.P. Morgan Healthcare Conference. Pfizer racked up its third deal of the week in a cancer collaboration with Dren Bio.